Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort-Results of an International Multicenter Randomized Controlled Trial

被引:20
作者
Gearry, Richard [1 ]
Fukudo, Shin [2 ,3 ]
Barbara, Giovanni [4 ]
Kuhn-Sherlock, Barbara [5 ]
Ansell, Juliet [6 ]
Blatchford, Paul [6 ]
Eady, Sarah [7 ,8 ]
Wallace, Alison [7 ,8 ]
Butts, Christine [7 ,8 ]
Cremon, Cesare [4 ]
Barbaro, Maria Raffaella [4 ]
Pagano, Isabella [4 ]
Okawa, Yohei [2 ]
Muratubaki, Tomohiko [2 ]
Okamoto, Tomoko [9 ]
Fuda, Mikiko [10 ]
Endo, Yuka [3 ]
Kano, Michiko [2 ]
Kanazawa, Motoyori [2 ,3 ]
Nakaya, Naoki [11 ]
Nakaya, Kumi [11 ]
Drummond, Lynley
机构
[1] Univ Otago, Dept Med, Christchurch, New Zealand
[2] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Japan
[3] Tohoku Univ Hosp, Dept Psychosomat Med, Sendai, Japan
[4] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[5] BKS Consulting Ltd, Hamilton, Waikato, New Zealand
[6] Zespri Int Ltd, Tauranga, New Zealand
[7] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand
[8] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand
[9] Sapporo Univ Hlth Sci, Dept Nutr, Sapporo, Japan
[10] Tohoku Univ Hosp, Dept Clin Nutr, Sendai, Japan
[11] Tohoku Univ, Dept Prevent Med & Epidemiol, Tohoku Med Megabank Org, Sendai, Japan
关键词
Kiwifruit; constipation; irritable bowel syndrome; GI comfort; IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; GASTROINTESTINAL SYMPTOMS; SEVERITY; PSYLLIUM; PRUNES; DESIGN; SYSTEM; SCALE;
D O I
10.14309/ajg.0000000000002124
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION:Consumption of green kiwifruit is known to relieve constipation. Previous studies have also reported improvements in gastrointestinal (GI) comfort. We investigated the effect of consuming green kiwifruit on GI function and comfort.METHODS:Participants included healthy controls (n = 63), patients with functional constipation (FC, n = 60), and patients with constipation-predominant irritable bowel syndrome (IBS-C, n = 61) randomly assigned to consume 2 green kiwifruits or psyllium (7.5 g) per day for 4 weeks, followed by a 4-week washout, and then the other treatment for 4 weeks. The primary outcome was the number of complete spontaneous bowel movements (CSBM) per week. Secondary outcomes included GI comfort which was measured using the GI symptom rating scale, a validated instrument. Data (intent-to-treat) were analyzed as difference from baseline using repeated measures analysis of variance suitable for AB/BA crossover design.RESULTS:Consumption of green kiwifruit was associated with a clinically relevant increase of >= 1.5 CSBM per week (FC; 1.53, P < 0.0001, IBS-C; 1.73, P = 0.0003) and significantly improved measures of GI comfort (GI symptom rating scale total score) in constipated participants (FC, P < 0.0001; IBS-C, P < 0.0001). No significant adverse events were observed.DISCUSSION:This study provides original evidence that the consumption of a fresh whole fruit has demonstrated clinically relevant increases in CSBM and improved measures of GI comfort in constipated populations. Green kiwifruits are a suitable dietary treatment for relief of constipation and associated GI comfort.
引用
收藏
页码:1058 / 1068
页数:11
相关论文
共 42 条
  • [31] Moayyedi Paul, 2019, J Can Assoc Gastroenterol, V2, P6, DOI 10.1093/jcag/gwy071
  • [32] Peery AF, 2019, GASTROENTEROLOGY, V156, P254, DOI [10.1053/j.gastro.2015.08.045, 10.1053/j.gastro.2018.08.063]
  • [33] Kiwifruit promotes laxation in the elderly
    Rush, EC
    Patel, M
    Plank, LD
    Ferguson, LR
    [J]. ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2002, 11 (02) : 164 - 168
  • [34] Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation
    Shin, A.
    Camilleri, M.
    Kolar, G.
    Erwin, P.
    West, C. P.
    Murad, M. H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (03) : 239 - 253
  • [35] Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
    Sperber, Ami D.
    Bangdiwala, Shrikant, I
    Drossman, Douglas A.
    Ghoshal, Uday C.
    Simren, Magnus
    Tack, Jan
    Whitehead, William E.
    Dumitrascu, Dan L.
    Fang, Xuicai
    Fukudo, Shin
    Kellow, John
    Okeke, Edith
    Quigley, Eamonn M. M.
    Schmulson, Max
    Whorwell, Peter
    Archampong, Timothy
    Adibi, Payman
    Andresen, Viola
    Benninga, Marc A.
    Bonaz, Bruno
    Bor, Serhat
    Fernandez, Luis Bustos
    Choi, Suck Chei
    Corazziari, Enrico S.
    Francisconi, Carlos
    Hani, Albis
    Lazebnik, Leonid
    Lee, Yeong Yeh
    Mulak, Agata
    Rahman, M. Masudur
    Santos, Javier
    Setshedi, Mashiko
    Syam, Ari Fahrial
    Vanner, Stephen
    Wong, Reuben K.
    Lopez-Colombo, Aurelio
    Costa, Valeria
    Dickman, Ram
    Kanazawa, Motoyori
    Keshteli, Ammar Hassanzadeh
    Khatun, Rutaba
    Maleki, Iradj
    Poitras, Pierre
    Pratap, Nitesh
    Stefanyuk, Oksana
    Thomson, Sandie
    Zeevenhooven, Judith
    Palsson, Olafur S.
    [J]. GASTROENTEROLOGY, 2021, 160 (01) : 99 - +
  • [36] GSRS - A CLINICAL RATING-SCALE FOR GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PEPTIC-ULCER DISEASE
    SVEDLUND, J
    SJODIN, I
    DOTEVALL, G
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (02) : 129 - 134
  • [37] Green kiwifruit (lat. Actinidia deliciosa var. Hayward) and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Turck, Dominique
    Castenmiller, Jacqueline
    De Henauw, Stefaan
    Hirsch-Ernst, Karen Ildico
    Kearney, John
    Knutsen, Helle Katrine
    Maciuk, Alexandre
    Mangelsdorf, Inge
    McArdle, Harry J.
    Naska, Androniki
    Pelaez, Carmen
    Pentieva, Kristina
    Thies, Frank
    Tsabouri, Sophia
    Vinceti, Marco
    Bresson, Jean-Louis
    Siani, Alfonso
    [J]. EFSA JOURNAL, 2021, 19 (06)
  • [38] US. Department of Health and Human Services Food and Drug Administration (FDA) Centre for Drug Evaluation and Research (CDER), 2012, Guidance for industry: irritable bowel syndrome-clinical evaluation of drugs for treatment
  • [39] On the Proper Use of the Crossover Design in Clinical Trials Part 18 of a Series on Evaluation of Scientific Publications
    Wellek, Stefan
    Blettner, Maria
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2012, 109 (15): : 276 - 281
  • [40] Mechanisms underlying effects of kiwifruit on intestinal function shown by MRI in healthy volunteers
    Wilkinson-Smith, Victoria
    Dellschaft, Neele
    Ansell, Juliet
    Hoad, Caroline
    Marciani, Luca
    Gowland, Penny
    Spiller, Robin
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (06) : 759 - 768